Blood Pressure Medication Recalled Nationwide—Over 13,000 Bottles Affected
Here’s what the FDA wants you to know.
A nationwide recall of chlorthalidone tablets is due to failed dissolution specifications, per the FDA.
Over 13,000 bottles of the 25-milligram tablets with batch number RISA24002 are affected.
If your medication matches the recall, return it to your pharmacy for a replacement or refund.
There's an active recall on a blood pressure medication prescribed and distributed nationwide, according to the U.S. Food and Drug Administration (FDA). This is due to "failed dissolution specifications."
The medication being recalled is 25-milligram chlorthalidone tablets manufactured by Inventia Healthcare Limited and sold in 100-count bottles. Approximately 13,567 bottles are affected, all of which contain NDC "64980-599-01," batch number "RISA24002" and an expiration date written as "4/2027."
If you take chlorthalidone, check your medication. If your prescription matches the above information, return to your pharmacy for a potential replacement or refund.
This recall has been labeled as a Class II recall, meaning that it may lead to minor, temporary health problems. While there are no illnesses connected to this recall, seek medical attention with any health concerns.
For questions, contact the FDA by calling 1-888-INFO-FDA (1-888-463-6332).
Topics in this story
Gathered from external sources. Rights to this text belong to whoever originally published it.